Companion Diagnostics Market Report by Product & Service (Assays, Kits and Reagents, Software and Services), Technology (Immunohistochemistry (IHC), Polymerase Chain Reaction (PCR), In-situ Hybridization (ISH), Real-time PCR (RT-PCR), Gene Sequencing, and Others), Indication (Cancer, Neurological Diseases, Infectious Diseases, Cardiovascular Diseases, and Others), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations, and Others), and Region 2023-2028
The global companion diagnostics market size reached US$ 5.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 13.3 Billion by 2028, exhibiting a growth rate (CAGR) of 14.5% during 2022-2028. The increasing prevalence of cancer, the surging demand for personalized medicine, and ongoing technological advancements, such as next-generation sequencing (NGS), represent some of the key factors driving the market.
Companion diagnostics are medical tests that help physicians determine the most effective treatment plan. These tests are designed to identify specific biomarkers in a patient's tissue or blood sample, indicating whether the patient will likely benefit from a particular drug or therapy. They also analyze the detailed biological profile and the mechanism of action (MOA) of patients and assist medical professionals in understanding the potential side effects of medications. Companion diagnostics are widely used across personalized medicines as it considers each patient's unique characteristics, such as their genetic makeup, to determine the best treatment plan. In addition to this, they are increasingly used for testing specific genetic mutations in cancer patients or biomarkers in patients with hepatitis C. This helps physicians tailor treatments to individual patients, improving the likelihood of successful outcomes and reducing the risk of side effects.
Companion Diagnostics Market Trends:
The rising instances of various kinds of cancer across the globe are impelling the demand for more effective and targeted cancer treatments, which is primarily driving the market growth. Companion diagnostics help identify patients who are most likely to benefit from specific cancer therapies, resulting in better patient outcomes. Moreover, the growing demand for personalized medicines tailored to each patient's unique characteristics is creating a favorable outlook for the market. Concurrent with this, the widespread adoption of targeted drugs and therapies for treating numerous infectious, cardiovascular, neurological, and inflammatory conditions is acting as another significant growth-inducing factor. In addition to this, the favorable regulatory landscape for companion diagnostics, with an increasing number of tests receiving approval from governing authorities such as the United States Food and Drug Administration (US FDA), and the expanding number of clinical trials around the world are strengthening the market growth. Furthermore, ongoing advancements in diagnostic technologies, such as the emergence of next-generation sequencing (NGS) and liquid biopsy, which have allowed identifying biomarkers that were formerly difficult to detect, are contributing to the market growth. Besides this, the development of innovative genomic technologies, which have enabled the identification of genetic mutations and other biomarkers that can be used to guide treatment decisions, is fueling the market growth. Other factors, such as the rising use of biomarkers in drug development, extensive investments in precision medicine, and the escalating consumer awareness regarding the benefits of companion diagnostics, are presenting remunerative growth opportunities for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global companion diagnostics market report, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on product & service, technology, indication, and end user.
Product & Service Insights:
Assays, Kits and Reagents
Software and Services
The report has provided a detailed breakup and analysis of the companion diagnostics market based on the product & service. This includes assays, kits and reagents, and software and services. According to the report, assays, kits, and reagents represented the largest segment.
Technology Insights:
Immunohistochemistry (IHC)
Polymerase Chain Reaction (PCR)
In-situ Hybridization (ISH)
Real-time PCR (RT-PCR)
Gene Sequencing
Others
A detailed breakup and analysis of the companion diagnostics market based on technology has also been provided in the report. This includes immunohistochemistry (IHC), polymerase chain reaction (PCR), in-situ hybridization (ISH), real-time PCR (RT-PCR), gene sequencing, and others. According to the report, polymerase chain reaction (PCR) accounted for the largest market share.
Indication Insights:
Cancer
Lung Cancer
Breast Cancer
Colorectal Cancer
Gastric Cancer
Melanoma
Others
Neurological Diseases
Infectious Diseases
Cardiovascular Diseases
Others
The report has provided a detailed breakup and analysis of the companion diagnostics market based on the indication. This includes cancer (lung cancer, breast cancer, colorectal cancer, gastric cancer, melanoma, and others), neurological diseases, infectious diseases, cardiovascular diseases, and others. According to the report, cancer represented the largest segment.
End User Insights:
Pharmaceutical & Biopharmaceutical Companies
Reference Laboratories
Contract Research Organizations
Others
A detailed breakup and analysis of the companion diagnostics market based on the end user has also been provided in the report. This includes pharmaceutical & biopharmaceutical companies, reference laboratories, contract research organizations, and others. According to the report, pharmaceutical & biopharmaceutical companies accounted for the largest market share.
Regional Insights:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for companion diagnostics. Some of the factors driving the North America companion diagnostics market included the growing prevalence of cancer, the rising adoption of personalized medicines and targeted therapies, and significant advancements in next-generation sequencing (NGS).
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global companion diagnostics market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, Agilent Technologies, BioMerieux, Danaher Corporation, Roche Holding AG, Myriad Genetics Inc., Siemens Healthcare, and Thermo Fisher Scientific Inc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report
1. What was the size of the global companion diagnostics market in 2022?
2. What is the expected growth rate of the global companion diagnostics market during 2023-2028?
3. What has been the impact of COVID-19 on the global companion diagnostics market?
4. What are the key factors driving the global companion diagnostics market?
5. What is the breakup of the global companion diagnostics market based on the product & service?
6. What is the breakup of the global companion diagnostics market based on the technology?
7. What is the breakup of the global companion diagnostics market based on the indication?
8. What is the breakup of the global companion diagnostics market based on the end user?
9. What are the key regions in the global companion diagnostics market?
10. Who are the key players/companies in the global companion diagnostics market?
Companion diagnostics are medical tests that help physicians determine the most effective treatment plan. These tests are designed to identify specific biomarkers in a patient's tissue or blood sample, indicating whether the patient will likely benefit from a particular drug or therapy. They also analyze the detailed biological profile and the mechanism of action (MOA) of patients and assist medical professionals in understanding the potential side effects of medications. Companion diagnostics are widely used across personalized medicines as it considers each patient's unique characteristics, such as their genetic makeup, to determine the best treatment plan. In addition to this, they are increasingly used for testing specific genetic mutations in cancer patients or biomarkers in patients with hepatitis C. This helps physicians tailor treatments to individual patients, improving the likelihood of successful outcomes and reducing the risk of side effects.
Companion Diagnostics Market Trends:
The rising instances of various kinds of cancer across the globe are impelling the demand for more effective and targeted cancer treatments, which is primarily driving the market growth. Companion diagnostics help identify patients who are most likely to benefit from specific cancer therapies, resulting in better patient outcomes. Moreover, the growing demand for personalized medicines tailored to each patient's unique characteristics is creating a favorable outlook for the market. Concurrent with this, the widespread adoption of targeted drugs and therapies for treating numerous infectious, cardiovascular, neurological, and inflammatory conditions is acting as another significant growth-inducing factor. In addition to this, the favorable regulatory landscape for companion diagnostics, with an increasing number of tests receiving approval from governing authorities such as the United States Food and Drug Administration (US FDA), and the expanding number of clinical trials around the world are strengthening the market growth. Furthermore, ongoing advancements in diagnostic technologies, such as the emergence of next-generation sequencing (NGS) and liquid biopsy, which have allowed identifying biomarkers that were formerly difficult to detect, are contributing to the market growth. Besides this, the development of innovative genomic technologies, which have enabled the identification of genetic mutations and other biomarkers that can be used to guide treatment decisions, is fueling the market growth. Other factors, such as the rising use of biomarkers in drug development, extensive investments in precision medicine, and the escalating consumer awareness regarding the benefits of companion diagnostics, are presenting remunerative growth opportunities for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global companion diagnostics market report, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on product & service, technology, indication, and end user.
Product & Service Insights:
Assays, Kits and Reagents
Software and Services
The report has provided a detailed breakup and analysis of the companion diagnostics market based on the product & service. This includes assays, kits and reagents, and software and services. According to the report, assays, kits, and reagents represented the largest segment.
Technology Insights:
Immunohistochemistry (IHC)
Polymerase Chain Reaction (PCR)
In-situ Hybridization (ISH)
Real-time PCR (RT-PCR)
Gene Sequencing
Others
A detailed breakup and analysis of the companion diagnostics market based on technology has also been provided in the report. This includes immunohistochemistry (IHC), polymerase chain reaction (PCR), in-situ hybridization (ISH), real-time PCR (RT-PCR), gene sequencing, and others. According to the report, polymerase chain reaction (PCR) accounted for the largest market share.
Indication Insights:
Cancer
Lung Cancer
Breast Cancer
Colorectal Cancer
Gastric Cancer
Melanoma
Others
Neurological Diseases
Infectious Diseases
Cardiovascular Diseases
Others
The report has provided a detailed breakup and analysis of the companion diagnostics market based on the indication. This includes cancer (lung cancer, breast cancer, colorectal cancer, gastric cancer, melanoma, and others), neurological diseases, infectious diseases, cardiovascular diseases, and others. According to the report, cancer represented the largest segment.
End User Insights:
Pharmaceutical & Biopharmaceutical Companies
Reference Laboratories
Contract Research Organizations
Others
A detailed breakup and analysis of the companion diagnostics market based on the end user has also been provided in the report. This includes pharmaceutical & biopharmaceutical companies, reference laboratories, contract research organizations, and others. According to the report, pharmaceutical & biopharmaceutical companies accounted for the largest market share.
Regional Insights:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for companion diagnostics. Some of the factors driving the North America companion diagnostics market included the growing prevalence of cancer, the rising adoption of personalized medicines and targeted therapies, and significant advancements in next-generation sequencing (NGS).
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global companion diagnostics market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, Agilent Technologies, BioMerieux, Danaher Corporation, Roche Holding AG, Myriad Genetics Inc., Siemens Healthcare, and Thermo Fisher Scientific Inc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report
1. What was the size of the global companion diagnostics market in 2022?
2. What is the expected growth rate of the global companion diagnostics market during 2023-2028?
3. What has been the impact of COVID-19 on the global companion diagnostics market?
4. What are the key factors driving the global companion diagnostics market?
5. What is the breakup of the global companion diagnostics market based on the product & service?
6. What is the breakup of the global companion diagnostics market based on the technology?
7. What is the breakup of the global companion diagnostics market based on the indication?
8. What is the breakup of the global companion diagnostics market based on the end user?
9. What are the key regions in the global companion diagnostics market?
10. Who are the key players/companies in the global companion diagnostics market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL COMPANION DIAGNOSTICS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT & SERVICE
6.1 Assays, Kits and Reagents
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Software and Services
6.2.1 Market Trends
6.2.2 Market Forecast
7 MARKET BREAKUP BY TECHNOLOGY
7.1 Immunohistochemistry (IHC)
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Polymerase Chain Reaction (PCR)
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 In-situ Hybridization (ISH)
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Real-time PCR (RT-PCR)
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Gene Sequencing
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 MARKET BREAKUP BY INDICATION
8.1 Cancer
8.1.1 Market Trends
8.1.2 Major Types
8.1.2.1 Lung Cancer
8.1.2.2 Breast Cancer
8.1.2.3 Colorectal Cancer
8.1.2.4 Gastric Cancer
8.1.2.5 Melanoma
8.1.2.6 Others
8.1.3 Market Forecast
8.2 Neurological Diseases
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Infectious Diseases
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Cardiovascular Diseases
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 MARKET BREAKUP BY END USER
9.1 Pharmaceutical & Biopharmaceutical Companies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Reference Laboratories
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Contract Research Organizations
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Agilent Technologies
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 BioMerieux
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Danaher Corporation
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Roche Holding AG
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 SWOT Analysis
15.3.6 Myriad Genetics Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Siemens Healthcare
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Thermo Fisher Scientific Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL COMPANION DIAGNOSTICS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT & SERVICE
6.1 Assays, Kits and Reagents
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Software and Services
6.2.1 Market Trends
6.2.2 Market Forecast
7 MARKET BREAKUP BY TECHNOLOGY
7.1 Immunohistochemistry (IHC)
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Polymerase Chain Reaction (PCR)
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 In-situ Hybridization (ISH)
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Real-time PCR (RT-PCR)
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Gene Sequencing
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 MARKET BREAKUP BY INDICATION
8.1 Cancer
8.1.1 Market Trends
8.1.2 Major Types
8.1.2.1 Lung Cancer
8.1.2.2 Breast Cancer
8.1.2.3 Colorectal Cancer
8.1.2.4 Gastric Cancer
8.1.2.5 Melanoma
8.1.2.6 Others
8.1.3 Market Forecast
8.2 Neurological Diseases
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Infectious Diseases
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Cardiovascular Diseases
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 MARKET BREAKUP BY END USER
9.1 Pharmaceutical & Biopharmaceutical Companies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Reference Laboratories
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Contract Research Organizations
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Agilent Technologies
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 BioMerieux
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Danaher Corporation
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Roche Holding AG
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 SWOT Analysis
15.3.6 Myriad Genetics Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Siemens Healthcare
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Thermo Fisher Scientific Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
LIST OF TABLES
Table 1: Global: Companion Diagnostics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Companion Diagnostics Market Forecast: Breakup by Product & Service (in Million US$), 2023-2028
Table 3: Global: Companion Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2023-2028
Table 4: Global: Companion Diagnostics Market Forecast: Breakup by Indication (in Million US$), 2023-2028
Table 5: Global: Companion Diagnostics Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 6: Global: Companion Diagnostics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Companion Diagnostics Market Structure
Table 8: Global: Companion Diagnostics Market: Key Players
Table 1: Global: Companion Diagnostics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Companion Diagnostics Market Forecast: Breakup by Product & Service (in Million US$), 2023-2028
Table 3: Global: Companion Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2023-2028
Table 4: Global: Companion Diagnostics Market Forecast: Breakup by Indication (in Million US$), 2023-2028
Table 5: Global: Companion Diagnostics Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 6: Global: Companion Diagnostics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Companion Diagnostics Market Structure
Table 8: Global: Companion Diagnostics Market: Key Players
LIST OF FIGURES
Figure 1: Global: Companion Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Companion Diagnostics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Companion Diagnostics Market: Breakup by Product & Service (in %), 2022
Figure 4: Global: Companion Diagnostics Market: Breakup by Technology (in %), 2022
Figure 5: Global: Companion Diagnostics Market: Breakup by Indication (in %), 2022
Figure 6: Global: Companion Diagnostics Market: Breakup by End User (in %), 2022
Figure 7: Global: Companion Diagnostics Market: Breakup by Region (in %), 2022
Figure 8: Global: Companion Diagnostics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 9: Global: Companion Diagnostics (Assays, Kits and Reagents) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Companion Diagnostics (Assays, Kits and Reagents) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Companion Diagnostics (Software and Services) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Companion Diagnostics (Software and Services) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Companion Diagnostics (Immunohistochemistry) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Companion Diagnostics (Immunohistochemistry) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Companion Diagnostics (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Companion Diagnostics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Companion Diagnostics (In-situ Hybridization) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Companion Diagnostics (In-situ Hybridization) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Companion Diagnostics (Real-time PCR) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Companion Diagnostics (Real-time PCR) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Companion Diagnostics (Gene Sequencing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Companion Diagnostics (Gene Sequencing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Companion Diagnostics (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Companion Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Companion Diagnostics (Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Companion Diagnostics (Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Companion Diagnostics (Neurological Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Companion Diagnostics (Neurological Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Companion Diagnostics (Infectious Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Companion Diagnostics (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Companion Diagnostics (Cardiovascular Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Companion Diagnostics (Cardiovascular Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Companion Diagnostics (Other Indications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Companion Diagnostics (Other Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Companion Diagnostics (Pharmaceutical & Biopharmaceutical Companies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Companion Diagnostics (Pharmaceutical & Biopharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Global: Companion Diagnostics (Reference Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Global: Companion Diagnostics (Reference Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Global: Companion Diagnostics (Contract Research Organizations) Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Global: Companion Diagnostics (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Global: Companion Diagnostics (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Global: Companion Diagnostics (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: North America: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: North America: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: United States: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: United States: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Canada: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Canada: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Asia Pacific: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Asia Pacific: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: China: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: China: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Japan: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Japan: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: India: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: India: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: South Korea: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: South Korea: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Australia: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Australia: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Indonesia: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Indonesia: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Others: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Others: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Europe: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Europe: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Germany: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Germany: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: France: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: France: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: United Kingdom: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: United Kingdom: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Italy: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Italy: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Spain: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Spain: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Russia: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Russia: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Others: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Others: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Latin America: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Latin America: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Brazil: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Brazil: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: Mexico: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 86: Mexico: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 87: Others: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 88: Others: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 89: Middle East and Africa: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 90: Middle East and Africa: Companion Diagnostics Market: Breakup by Country (in %), 2022
Figure 91: Middle East and Africa: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 92: Global: Companion Diagnostics Industry: SWOT Analysis
Figure 93: Global: Companion Diagnostics Industry: Value Chain Analysis
Figure 94: Global: Companion Diagnostics Industry: Porter’s Five Forces Analysis
Figure 1: Global: Companion Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Companion Diagnostics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Companion Diagnostics Market: Breakup by Product & Service (in %), 2022
Figure 4: Global: Companion Diagnostics Market: Breakup by Technology (in %), 2022
Figure 5: Global: Companion Diagnostics Market: Breakup by Indication (in %), 2022
Figure 6: Global: Companion Diagnostics Market: Breakup by End User (in %), 2022
Figure 7: Global: Companion Diagnostics Market: Breakup by Region (in %), 2022
Figure 8: Global: Companion Diagnostics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 9: Global: Companion Diagnostics (Assays, Kits and Reagents) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Companion Diagnostics (Assays, Kits and Reagents) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Companion Diagnostics (Software and Services) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Companion Diagnostics (Software and Services) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Companion Diagnostics (Immunohistochemistry) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Companion Diagnostics (Immunohistochemistry) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Companion Diagnostics (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Companion Diagnostics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Companion Diagnostics (In-situ Hybridization) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Companion Diagnostics (In-situ Hybridization) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Companion Diagnostics (Real-time PCR) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Companion Diagnostics (Real-time PCR) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Companion Diagnostics (Gene Sequencing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Companion Diagnostics (Gene Sequencing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Companion Diagnostics (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Companion Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Companion Diagnostics (Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Companion Diagnostics (Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Companion Diagnostics (Neurological Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Companion Diagnostics (Neurological Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Companion Diagnostics (Infectious Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Companion Diagnostics (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Companion Diagnostics (Cardiovascular Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Companion Diagnostics (Cardiovascular Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Companion Diagnostics (Other Indications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Companion Diagnostics (Other Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Companion Diagnostics (Pharmaceutical & Biopharmaceutical Companies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Companion Diagnostics (Pharmaceutical & Biopharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Global: Companion Diagnostics (Reference Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Global: Companion Diagnostics (Reference Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Global: Companion Diagnostics (Contract Research Organizations) Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Global: Companion Diagnostics (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Global: Companion Diagnostics (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Global: Companion Diagnostics (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: North America: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: North America: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: United States: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: United States: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Canada: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Canada: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Asia Pacific: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Asia Pacific: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: China: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: China: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Japan: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Japan: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: India: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: India: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: South Korea: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: South Korea: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Australia: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Australia: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Indonesia: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Indonesia: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Others: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Others: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Europe: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Europe: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Germany: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Germany: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: France: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: France: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: United Kingdom: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: United Kingdom: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Italy: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Italy: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Spain: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Spain: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Russia: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Russia: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Others: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Others: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Latin America: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Latin America: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Brazil: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Brazil: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: Mexico: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 86: Mexico: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 87: Others: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 88: Others: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 89: Middle East and Africa: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 90: Middle East and Africa: Companion Diagnostics Market: Breakup by Country (in %), 2022
Figure 91: Middle East and Africa: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 92: Global: Companion Diagnostics Industry: SWOT Analysis
Figure 93: Global: Companion Diagnostics Industry: Value Chain Analysis
Figure 94: Global: Companion Diagnostics Industry: Porter’s Five Forces Analysis
